Immunosupressive therapy for primary biliary cirrhosis
References (61)
- et al.
Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis
Gastroenterology
(1980) - et al.
Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriaceae?
Lancet
(1988) - et al.
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis
Lancet
(1989) - et al.
Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis
Lancet
(1984) - et al.
d-penicillamine treatment improves survival in primary biliary cirrhosis
Lancet
(1981) - et al.
A prospective controlled trial of azathioprine in primary biliary cirrhosis
Gastroenterology
(1976) - et al.
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Gastroenterology
(1985) - et al.
Evaluation of colchicine therapy in primary biliary cirrhosis
Gastroenterology
(1988) - et al.
A controlled trial of colchicine in primary biliary cirrhosis
J Hepatol
(1987) - et al.
Randomized trial of chlorambucil for primary biliary cirrhosis
Gastroenterology
(1986)
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis
Gastroenterology
(1988)
Survival in asymptomatic primary biliary cirrhosis
Gastroenterology
(1990)
Asymptomatic primary biliary cirrhosis
Gastroenterology
(1985)
Diminished survival in asymptomatic primary biliary cirrhosis
Gastroenterology
(1990)
Symptom development and prognosis in primary biliary cirrhosis: a study in two centers
Gastroenterology
(1990)
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial
Gastroenterology
(1989)
FK 506: an immunosuppressant for the 1990s?
Lancet
(1991)
Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1, 1-biphosphonate (APD)
Lancet
(1988)
Primary biliary cirrhosis
N Engl J Med
(1987)
Primary biliary cirrhosis: a model autoimmune disease
Ann Intern Med
(1983)
Suppressor cell activity in primary biliary cirrhosis
Dig Dis Sci
(1980)
Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelium in primary biliary cirrhosis
Hepatology
(1986)
Lymphocytes in liver disease
Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis
Hepatology
(1988)
d-penicillamine in primary biliary cirrhosis: two years results of a single centre, double-blind controlled trial
Gut
(1980)
Controlled trial of high and low dose d-penicillamine in primary biliary cirrhosis (PBC): results at three years
Gut
(1982)
A prospective trial of d-penicillamine in primary biliary cirrhosis
N Engl J Med
(1982)
Low therapeutic value of d-penicillamine in a short-term prospective trial in primary biliary cirrhosis
Liver
(1983)
Trial on penicillamine in advanced primary biliary cirrhosis
N Engl J Med
(1985)
Double-blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis
Gut
(1985)
Cited by (14)
Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis?
1995, Journal of HepatologyThalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study
1994, Journal of HepatologyPrimary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation
1993, Journal of HepatologyGlucocorticosteroids for primary biliary cirrhosis
2005, Cochrane Database of Systematic ReviewsAutoimmune liver disease
2004, Annals of Gastroenterology
Copyright © 1992 Published by Elsevier Ireland Ltd.